Home : Unsafe Drugs : Byetta : News Articles

Byetta - News Articles

Lizard venom offers hope for Parkinson's disease patients: to establish whether the drug 'Exenatide' could be used to treat patients with the progressive neurological condition. A synthetic version of this drug, originally found in the saliva of the Gila monster, is already an approved treatment for patients with diabetes. However, ...
StreetInsider.com - Barclays Maintains an 'Overweight' Rating on Amylin Pharmaceuticals (AMLN); TRx Share Continues to Increase Byetta Losing Share in GLPs: Barclays analys says,"IMS Health prescription data reported this morning suggests flat scrips sequentially for GLP-1 TRx and NRx, Byetta TRx and NRx, and Victoza NRx with an increase in Victoza TRx. Byetta market share within the GLP-1 category continued its decreasing ...
Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and Baird Glo: Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes ...
A Potential New Market for Byetta?: Cincinatti, OH: Type 2 diabetes drug Byetta, thought to be associated with acute pancreatitis and various other side effects, may one day put at risk an even wider range of patients. Thatâ€™s because an injectable form of Byetta is being considered for the treatment of ...
"Byetta is a Bad Drug": Mobile, AL: Donald, 72, a retired attorney, a type 2 diabetic and a former Byetta user, says Byetta is not to be trusted. "I want to get the word out that Byetta is a bad drug, and I want to help get it off the market." says Donald. "Why would ...
Health Concerns Partially Cause Byetta to Lose Ground in Diabetes Market: Princeton, NJ: A new diabetes drug introduced earlier this year will likely challenge Eli Lilly's Byetta for control of the diabetes medication market. Novo Nordisk's Victoza was introduced in America this past February and has quickly gained ground on rival diabetes drugs, ...
DURATION-4 Study Results: BYDUREON™ Efficacy and Tolerability Profile Extended to Monotherapy Treatment | Business Wire: BYDUREON is a once-weekly formulation of exenatide, the active ingredient in BYETTA ® (exenatide) injection, which has been available in the US since June ...

Will New Byetta Weekly Injection Carry Similar Concerns?: Washington, DC: Despite growing concerns over the link between Byetta and acute pancreatitis, the manufacturers of Byetta plan to introduce a longer-acting form of the medication to be taken just once weekly. The US Food and Drug Administration (FDA) has set ...
Medical News: Once-a-Week Diabetes Drug Comparable to Standard Meds - in Endocrinology, Diabetes from MedPage Today: Forbes (blog)
An investigational once-weekly formulation of exenatide (Byetta) produced a greater reduction in hemoglobin A1c levels than sitagliptin (Januvia), but was not superior to two other standard diabetes medications, marketers of the drug ...
Log In Problems: In any diabetic patient with acute pancreatitis, exenatide must be ruled out as the cause and its use discontinued. Exenatide is a 39-amino acid synthetic ...
Byetta Rejected By FDA Over New Formula | Newsome Law: The US Food and Drug Administration has declined, at least until more information is provided, to approve a new formula for the drug Byetta, which is taken to regulate diabetes. The FDA said it needs more information about the manufacturing process used by the drug’s makers, ...
FDA Hedges Approval of Long-Acting Byetta, Asks Amylin for More Information - Diabetes Health: The US Food and Drug Administration has withheld approval of Bydureon, the once-weekly version of the popular type 2 diabetes drug Byetta. ...
Byetta Pancreatitis Case Offers New Evidence of Cause | Newsome Law: A recent case of pancreatitis in Cleveland, Ohio, presents the best documented evidence that the medication Byetta may be responsible for the disease. A diabetic woman began taking Byetta to treat her diabetes, and almost immediately contracted pancreatitis. When she ceased taking ...

Do you need a Washington, DC Byetta attorney? Contact one of our Washington, DC Byetta attorneys now.

Need A Byetta Attorney?

First Name Last Name Email Address State

Legal Issue

Unsafe Drugs: Byetta Click to select a Legal Issue

Was Your Health Negatively Affected?

Please Describe the Injury

close this window

Byetta Information

Click to View Our Legal Resources

Do you need a Washington, DC Byetta attorney? Contact one of our Washington, DC Byetta attorneys now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120223-092902

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

Unsafe Drugs: Byetta Click to select a Legal Issue

Close (x)

Find Legal Help for Your Byetta Case - Submit Your Information Below

Do you need legal assistance with your Byetta case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * Unsafe Drugs: Byetta Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.